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Abstract
The protein corona is still somewhat of a mysterious consequence of the nanoparticles’ 
application in theranostics. In this review, several critical aspects related to the protein 
corona are described, in particular which influences more specifically its formation, how 
to evaluate/characterize it, and what interactions to expect when the nanoparticle and the 
protein corona are inside the cell. Despite these issues, which have been studied in a gen-
eral way, it has been verified that there’s still much information missing when it comes 
to specific nanoparticles. Here, a few proteins are also highlighted as examples, which 
have been identified as part of the protein corona; in addition, several factors related to 
the formation of protein corona are discussed due to their important role in the different 
adsorbed proteins.
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1. Introduction
Nanotechnology is becoming everyday a more valuable resource in developing strategies 
of diagnostics and therapeutics; in fact, a new area is arising which is named nanomedicine 
[1]. From the use of nanoparticles [2] to nanorobots [3] or nanosensors [4], there is no short-
age of ways to apply it to nanomedicine’s benefit. Nanoparticles are particularly useful 
as theranostic agents, as a multifunctional platform which combine both therapeutic and 
diagnostic applications simultaneously [5]. However, nanoparticles must gather a number 
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of characteristics in order to be considered as good theranostic agents, such as suitable size 
[6] and shape [7] for cell penetration, biocompatibility, surface charge, efficient targeting 
[8], and fluorescence, among others [9]. Despite of these advantages and promising appli-
cations, there are still many problems associated to the entrance of the nanoparticle in a 
physiological environment, which may be justified with different intrinsic characteristics 
of the nanoparticles [10]. In general, there are two different nanoparticle identities, such as 
“synthetic identity,” which refers to their intentional physicochemical properties [11], and 
a “biological identity,” which is related to the physicochemical properties shown by the 
nanoparticle after its application in a physiological environment and interaction with the 
presented biomolecules [10]. This “biological identity” is profoundly related to the forma-
tion of the protein corona, as it significantly alters the size, shape, and surface charge of the 
nanoparticle [12, 13]. The protein corona is formed after the entrance of the nanoparticle in 
a physiological environment, such as the bloodstream and/or peripheral blood, where the 
presence of thousands of proteins [14] (among other biomolecules) causes their adsorption 
onto the nanoparticle surface [15], in a corona shape [16]. The formation of this corona is 
energetically favorable, with a decrease of enthalpy and increase of entropy [15]. It can be 
divided into two categories: a “hard” corona, and a “soft” corona. The “soft” corona is based 
on abundant proteins that firstly bind to the nanoparticle through low-affinity bonds, and the 
“hard” corona is more dense [17], based on sparse proteins that replace the “soft” proteins 
over time, due to their higher affinity bonds [11], which is known as the Vroman effect [18]. 
The composition of the corona is directly dependent on the biomolecular composition of the 
physiological environment that surrounds it [19, 20], the time of exposure [11, 17, 21], and also 
incubation conditions (such as temperature or mild stirring), among others. Moreover, it is 
clear that the protein corona is not static and varies in the course of time; in other words, it’s 
dynamic [17, 21]. Eventually, it will reach a state of equilibrium, steady stochastic state, where 
the association and dissociation rates for each protein occur equally [21], unless it is further 
incubated in a different biological media or proximal biological fluid, with a formation of a 
new corona [22]. The great majority of the proteins that form the corona are independent of 
the size and surface charge of the nanoparticle but are very influenced by the chemical prop-
erties of the material that constitutes the nanoparticle [23]. However, there are still sensitive 
proteins to size and surface charge, whose nature can change and consequently alter the 
interactions between nanoparticles and cells with the consequent alteration of the biological 
outcome and biological impacts [23]. For instance, if opsonins bind to the nanoparticle in 
the protein corona, they will be recognized as a “threat,” and consequently are phagocy-
tosed by macrophages [24]. It is crucial to prevent opsonization, “camouflage” the nanopar-
ticle to avoid the phagocytosis, and keep the nanoparticles in circulation, which can be 
achieved by the application of a polymer coating, such as poly(ethylene glycol) (PEG) [25]. 
This polymer coating also prevents the formation of the protein corona, which can later 
compromise the nanoparticle internalization by the cells [25]. It is thus important to study 
the influence of the protein corona in the internalization of the nanoparticle, as the interac-
tions of the nanoparticles with cells in in vivo studies are much different from the in vitro 
ones [26–28], which can prove to be an obstacle in the generalized application of this ther-
anostic approach based on nanomaterials.
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2. Characterization of protein corona by proteomic strategies
Since the formation of the protein corona has a great impact on the nanoparticle’s performance 
when applied to a biological system, it is important to assess its structure and composition, in 
order to minimize the adverse effects it may have on the nanoparticle’s use. Any alteration in 
shape, size, electron transfer, or others may come from the binding of the protein corona to the 
nanoparticle and may be used as parameters of comparison to be tested between nanoparti-
cles, before and after administration to a biological fluid [29]. However, it is necessary to sepa-
rate the nanoparticle-protein complex from the excess of plasma proteins [30] before assessing 
the composition of the protein corona. This is frequently made by centrifugation [30, 31], but 
it can have many adverse effects in the corona, due to the alterations caused by washing steps 
as well as gradient and volume variations [30, 32, 33]. In order to avoid loss of proteins from 
the corona, or even tainting the protein corona sample with the proteins in excess from the 
plasma, centrifugation can be accompanied by other procedures, such as size exclusion chro-
matography [32] or microfiltration [33, 34]. In the case of magnetic nanoparticles, a one-step 
centrifugation does not work, as it agglomerates the nanoparticles, making it necessary to 
perform a magnetic separation [35, 36]. As said by Megido et al. [33], the main methods of 
evaluation can be held as qualitative or quantitative, being summarized in Figure 1.
2.1. Quantitative proteomics
Quantitative proteomics is the collection of techniques that allow the determination of the 
number of proteins in a sample, which may be its absolute amount or just the relative change 
Figure 1. Summary of methodological approaches useful for the characterization of the protein corona (figure based on 
Megido et al. [33]).
Protein Interactions and Nanomaterials: A Key Role of the Protein Corona in Nanobiocompatibility
http://dx.doi.org/10.5772/intechopen.75501
31
in amounts between two states [37]. There are many problems associated to the methods used 
for these assays, such as difficulties in reproducing the results and lack of precision in the 
measurements [38, 39], but recent technologies have allowed to minimize such issues [40], 
increasing the depth and coverage [38], which can also be done by using several techniques 
simultaneously and by defining standards for reproducibility [39]. The most commonly used 
assays are isothermal titration calorimetry (ITC), UV-visible spectrometry, stable isotope 
labeling by amino acids in cell culture (SILAC), isobaric tag for relative and absolute quanti-
tation (iTRAQ), and label-free MS/MS quantification. There are also quantitative approaches 
that make use of two-dimensional electrophoresis (2-DE) [41], but it’s mostly used for qualita-
tive proteomics [39], due to the current limitations in performing quantitative assays .
2.1.1. Isothermal titration calorimetry (ITC)
Isothermal titration calorimetry is a method that allows the determination of thermodynamic 
parameters in a solution (binding affinity, binding stoichiometry, and binding enthalpy 
change [33]), in particular the ones coming from interactions between biological macromol-
ecules [42]. This process is based on the changes in heat caused by the protein adsorption 
to the nanoparticle [43]. The main advantage of this method relies on the fact that it allows 
the characterization while still in the incubation medium [43], which consequently allows a 
greater optimization of the nanoparticle.
2.1.2. UV-visible spectrometry
UV-visible spectrometry is a process based on the ratio between the passed light measured 
and the incident light in the UV-visible wavelength [33]. The presence of the protein corona 
induces changes on the absorption spectrum [17], which makes it an easy, fast, and applicable 
approach, as it requires no other chemicals or resources other than the protein corona itself 
[33]. However, it is an unreliable method, as the radiation energy reaching the sample is low 
[44]; it is very influenced by parameters such as size, temperature, pH [33], and equipment 
errors, which have a much bigger impact, as there is no other chemical or technique applied 
to lower the risk of incorrect results [44].
2.1.3. Stable isotope labeling by amino acids in cell culture (SILAC)
SILAC, an acronym to stable isotope labeling by amino acids in cell culture, is a procedure 
where an essential a.a. has been replaced by its stable isotope counterpart in the cells’ growth 
medium, making this “heavy” amino acid incorporated into all expressed proteins [45]. This 
causes the growth of two populations of cells: the ones growing in “light” medium containing 
the natural isotope in the amino acids and the ones growing in “heavy” medium containing 
stable isotope-labeled amino acids [33, 46]. After complete labeling, equal amounts of labeled 
and unlabeled cells or protein extracts are mixed in the cell population. The samples are then 
digested into peptides and then analyzed with mass spectrometry. The quantification of 
SILAC is thus based on the ratio of introduced isotope-labeled peptides to unlabeled peptides 
[46]. The many advantages of SILAC are its easy implementation, reasonable quantitative 
accuracy, and high reproducibility [46].
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2.1.4. Isobaric tag for relative and absolute quantitation (iTRAQ)
Isobaric tag for relative and absolute quantitation, also known as iTRAQ, is a widely used method 
in proteomics for quantification. It is based on mass spectrometry (MS) [47] and is useful in situ-
ations where the proteins come from different sources in the same sample [33]. This technique 
makes use of amine-reactive reagents with different isotopic masses between them [47], labeling 
the peptides differently and allowing for a clear distinction when analyzing MS scans, as vari-
ous peptides appear each in a single peak [33]. However, this method has a great disadvantage 
concerning its cost [48], which makes it impracticable when compared to cheaper alternatives.
2.1.5. Label-free MS/MS quantification
Label-free quantification methods make no use of labeling on the proteins, relying only on the 
measurement of ion intensity changes in chromatography or on spectrum counting of frag-
ments of peptides in a given protein [46]. This procedure is especially suited for biomarker 
discovery in large sample sets, as it is not needed labeling in any protein [49]. Labeling also 
limits the dynamic range, resulting in loss of signal and possible omission of proteins [50]. 
Therefore, using a label-free quantification approach allows the gathering of reliable informa-
tion, with great reproducibility [49].
2.2. Qualitative proteomics
Qualitative proteomics refers to the assays designed for identification of proteins in a sample 
and are often performed not only for identification but also for quantitative purposes, such as 
the abovementioned 2-DE electrophoresis [39]. Other assessments that allow identification of 
proteins are circular dichroism (CD), SDS-PAGE, fluorescence spectroscopy, shotgun MS/MS, 
selected reaction monitoring (SRM)/multiple reaction monitoring (MRM), Fourier transform 
infrared and Raman spectroscopy, nuclear magnetic resonance (NMR), and X-ray [33].
2.2.1. Circular dichroism
Circular dichroism is an assay based on the determination of the secondary structure, folding 
and binding properties of proteins [51], using the difference between the absorption of left 
and right circularly polarized light [52]. This method is based on the optic properties shown 
by the conformation of the protein, which can be altered when interacting with a nanopar-
ticle. The nanoparticle itself shows no influence in the light, as it is not a chiral compound [33], 
and it can also be used with small amounts of proteins (20 μg) in a short amount of time [51], 
making it a viable way of assessment. However, it has some limitations, such as unfeasibility 
with complex mixtures of proteins [33] and impossibility in obtaining residue-specific infor-
mation [51].
2.2.2. SDS-PAGE
One of the most used methods in proteomics, electrophoresis, is a procedure that separates 
proteins in a sample according to their charge. Using a gel of polyacrylamide, a protein solution 
is applied, and in relation to their charge, proteins will migrate across the gel [53]. The proteins 
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get sorted by molecular weight [53], and staining is needed with an appropriate pigment, for 
instance, Coomassie blue [54]. The molecular weight is then compared with the one shown by 
the markers, and a densitometry analysis is performed [33]. This procedure is suitable to char-
acterize the proteins that form the corona, comparing the proteins obtained from the plasma 
with the ones that are found in the corona. It is thus possible to verify exactly which ones get 
adsorbed to its surface and, therefore, the ones that have greater affinity to the nanoparticle [43].
2.2.3. Fluorescence spectroscopy
Fluorescence spectroscopy is a method that allows the measurement of the fluorescence of 
a compound, when excited at a given wavelength [33]. The fluorescence may come from 
the protein (intrinsic probes), the nanoparticle, or even a fluorophore added to the complex 
(extrinsic probes) [33, 55], which will be picked up by the amino groups and then detected in 
the fluorescence spectrometer [56].
2.2.4. Shotgun MS/MS
Shotgun proteomics is a widely used technique in proteomics for identifying proteins [57], 
with great sensitivity, making it a great influence in the discovery of clinically actionable bio-
markers [58]. To perform it, a complex mixture of proteins is separated by sequence-specific 
proteolysis, forming peptides that will then be separated in smaller fragments to be later 
analyzed by mass spectrometry [57]. Each peptide will have a mass associated to it, but since 
peptides may have the same a.a., but in a different arrangement, it is important to assess the 
sequence, which can be done by the ratios of its mass spectrum, that is, by MS/MS [57].
This method is often disregarded by researchers, due to its early problems in reproducibility 
and fallible nature [58, 59]. However, the development of bioinformatic tools has allowed a 
decrease in these problems, making it a viable option for proteomic research [57–59].
2.2.5. Selected reaction monitoring (SRM)/multiple reaction monitoring (MRM)
One of the ways frequently used in replacement of shotgun MS/MS is selected reaction 
monitoring (SRM) [60], also known as multiple reaction monitoring (MRM). This assay 
makes use of a triple-quadrupole mass spectrometer [60], where peptides from a previously 
digested protein go through. In the first analyzer, molecular ions with similar mass to the 
peptide are selected, followed by fragmentation of the peptide bonds in the second ana-
lyzer. Lastly, in the third and final analyzer, the fragmented ions from the peptide pieces are 
measured, originating a transition signal [61]. This method does not record any full-mass 
spectrum, increasing its sensitivity and allowing the detection of scarce proteins in complex 
mixtures [60].
2.2.6. Fourier transform infrared and Raman spectroscopy
FTIR is a procedure that gives information about the surface properties of the nanoparticle 
and the protein corona, as it allows the detection of its attachment [33]. Standard Raman 
Protein-Protein Interaction Assays34
spectroscopy is not normally used independently, and it’s usually meant to complement 
other methods, such as FTIR [62]. Together, they provide information about protein’s sec-
ondary structure [63], plus vibrational and rotational parameters.
2.2.7. Nuclear magnetic resonance (NMR)
NMR, which stands for nuclear magnetic resonance, is a form of evaluation of proteins, 
widely used to describe dendrimers, polymers, and fullerenes derivatives, characterizing 
structure, purity, and functionality [64] and their possible effects in membrane disruption 
[65]. Usually, it is used to analyze lipids, as they show high affinity for the nanoparticles 
[66], after a size exclusion chromatography [33]. It still has disadvantages; for instance, it 
cannot distinguish the distribution of targeting agent density on a population of nanopar-
ticles [64].
2.2.8. X-ray crystallography
Considered one of the primary sources of structural information about the protein-ligand 
complex [67], and it is based on the positions and intensities of the reflections as measured in 
the diffraction pattern of the crystal [67]. This method has big challenges associated to it, as 
the quantity of radiation needed may be excessive and cause damages to the proteins before 
a signal is obtained [68], and there are many uncertainties when applying it, such as identity 
or location of the proteins to be evaluated [67].
3. Nanoparticle’s intracellular trafficking
After the nanoparticle’s entry in the biological fluid, it is important to ensure its internaliza-
tion into the cells and intracellular transport, as the formation of the protein corona influences 
directly the cellular uptake and may also have a significant role on the success of the nanopar-
ticle or lack thereof [69]. Most of mammalian cells internalize the nanoparticles through pino-
cytosis, although big, specialized cells (such as macrophages) are able to do it by phagocytosis 
[70, 71], which is the uptake of large particles [70]. Some nanoparticles can also do it by pas-
sive penetration of the cellular membrane; however, if the nanoparticle is not small enough, 
it may deform the membrane [72] by forming holes or thinning it [73], increasing the cyto-
toxicity [71, 74]. Still, this mechanism is useful in drug delivery, as the nanoparticle travels 
directly to the cytosol, without making use of endocytic vesicles [74], promoting the reach of 
the intracellular targets [75]. Hence, it is necessary to take that into account, when designing 
the nanoparticle, as it may be possible to optimally design the surface of the selected nanopar-
ticle for drug delivery and avoid the membrane’s deformation [74]. As for the pinocytosis 
internalization, which is the cellular uptake of small particles (fluids and solutes), it has four 
different types of mechanisms [70] (Figure 2).
The physical properties of the nanoparticle such as size, net surface charge, and chemical 
composition determine which endocytosis process is chosen for the internalization [76], 
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although more than one mechanism can be used for the same nanoparticle [77, 78], and 
the formation of the protein corona may have a great influence in this choice [71]. The pro-
teins adsorbed on the nanoparticle give it its biological identity, and they may present a 
sequence that is not recognized by the cell as relevant or needed, preventing its endocytosis 
[79]. It was verified that nanoparticles without a protein corona have higher rates of cellular 
uptake but can also cause more damage to the cell and alter the cellular metabolism and cell 
cycle [79, 80]. Nevertheless, if the sequence of proteins in the protein corona is identified 
as relevant, the endocytosis mechanisms are activated, and the nanoparticle is internalized 
[79]. When binding to the cellular membrane, the protein corona does not separate itself 
from the nanoparticle [81], nor does it detache when inside the cell, being internalized as 
a single complex [82]. After internalization, the nanoparticle’s course must be followed by 
capturing its fluorescence, which can come from the nanoparticle itself or from a fluores-
cent dye added posteriorly. According to Guarnieri et al. [83], polystyrene nanoparticles 
follow a fairly diffuse pattern once inside the cell, which suggested no interaction between 
the nanoparticle and the cytosolic structures, in both situations with and without protein 
corona. This diffuse pattern can be explained by the nanoparticles being transported within 
the endocytic vesicles, whose movements are associated to the molecular motors, such as 
kinesin, myosin, and dynein [83, 84]. Therefore, Guarnieri et al. [83] report that, although 
the protein corona has some influence in the mechanisms of cellular uptake, it does not 
show an impact on the intracellular pathways taken by nanoparticles internalized by endo-
cytosis. While leaving the cell, exocytosis mechanisms are activated, and they are depen-
dent on proteins in the medium, because the proteins forming the corona interacted with 
biological systems inside the cells [76]. The exocytosis is also size, surface coating, and 
shape dependent, as smaller nanoparticles showed faster exocytosis rates and rod-shaped 
Figure 2. Summary of the different kinds of endocytosis (information based on Conner and Schmid [71]).
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nanoparticles showed more efficiency when compared to spherical nanoparticles [76, 85]. 
After performing its function within the cell, the nanoparticle is eventually cleared by the 
liver and spleen, where they can be kept for a long time, increasing the expected cytotoxic-
ity of the nanoparticle [76].
4. Interaction of nanoparticles with cell interfaces
After internalization, it is important not only to guarantee the achievement of the nanopar-
ticle’s function but also to evaluate its effects on cellular organelles [86], as the toxicity can-
not be too high, or it will ultimately exclude its use in nanomedicine. The understanding of 
the nanoparticles’ interaction with each cellular organelle is still fairly underdeveloped, as 
researchers tend to overlook the possible connections between the nanoparticle’s composi-
tion and the cellular response, focusing considerably more on its uptake [86]. Nonetheless, 
some studies have already been made to counteract this tendency, in order to give more 
information and also a better understanding of the nanoparticles’ real impact in the cell. 
According to the experiment performed by Bertoli et al. [78], it is possible to separate the 
organelles retaining the nanoparticle through magnetism, if the particle is designed to have 
magnetic properties. Their experiment [78] was based on separating the nanoparticle from 
the cell after internalization, in order to identify the proteins adsorbed to it, and determin-
ing their origin, according to the characteristic proteins from each cellular organelle. The 
nanoparticles were verified to have the majority of proteins (over 44%) coming from the 
endocytic pathway, while fewer than 5% came from each of the different organelles stud-
ied, such as nucleus, mitochondria, or peroxisomes. However, some proteins can overlap 
by belonging to more than one organelle [87], acting like a contamination, as they can 
induce errors in the examination results. Nevertheless, it can be inferred that the majority 
Figure 3. Summarization of the nanoparticle’s cellular internalization. The nanoparticles interact with the cell, which 
can lead to cellular uptake or accumulation of the nanoparticle in the cell membrane. If uptake occurs, the cell engulfs 
the nanoparticle within endocytic vesicles, which transport the nanoparticle while inside the cell. According to the 
experiments performed by Bertoli et al. [79], the majority of nanoparticles does not leave the endocytic vesicles to interact 
directly with other organelles. The nanoparticles are exocytosed afterwards, through lysosomes, to be cleared by the 
liver or spleen.
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of nanoparticles does not leave the endocytic vehicles to associate itself with the different 
organelles that are present on the cell, which can become a problem, if there is a specific 
intracellular target for the nanoparticle.
In order to find the internalization’s time distribution, Bertoli et al. [78] also performed a 
time-dependent experiment, evaluating the locations of the nanoparticles after submitting 
the cells to a short exposure. It was verified that, after only a few minutes, the presence of 
the nanoparticles was greater in early endocytosis’ organelles, with the total absence of 
lysosomal markers. Still, a more prolonged exposure (24 h) revealed a stronger nanopar-
ticle existence in lysosomes, without any proteins present in early endocytic organelles, 
indicating their concluding exocytosis from the cells. A similar experiment was previously 
performed by Shapero et al. [88], where by electron and fluorescence microscopy, the inter-
nalization pathway of SiO
2
 fluorescent-labeled nanoparticles was characterized. The results 
obtained also showed a greater number of nanoparticles in the early endocytic organelles 
after a short exposure, lessening those numbers as time passed and as the nanoparticle’s 
location progressed to lysosomal structures, suggesting its clearance mechanism from the 
cell. Shapero et al. [88] also verified a nonexistent association between the nanoparticles 
and the cellular organelles, consolidating the theory that the great majority of nanoparti-
cles does not leave or circulates outside the endocytic vehicles to interact with other organ-
elles (Figure 3).
5. A selection of relevant proteins identified in the protein corona
As mentioned before, the constitution of the protein corona is mainly dependent on the 
composition of the biological medium where it’s inserted [19, 20], as different physiologi-
cal environments have different proteins that compose them. The protein corona is also 
dependent on the time of exposure [11, 17, 20], chemical properties of the nanoparticle 
applied [23], and, in some cases, size and surface of the nanoparticle [23]. It is impossible 
to have a standard protein corona for a given nanoparticle, as each one will have a differ-
ent composition [15]. The best approach possible then is to characterize the most occurring 
proteins, in order to predict the behavior of the nanoparticle when inside the physiological 
system. This issue of research is still emergent, with promising outcomes to better adjust the 
nanoparticle to its function and environment. An example of protein corona evaluation is 
the work presented by Mirshafiee et al. [89], who assessed the differences between nanopar-
ticles with different coatings without a protein corona and the same nanoparticles with it 
adsorbed. Three different types of nanoparticles were used: the bare nanoparticle (with 
no coating), a nanoparticle with human serum albumin coating (HSA), and a nanoparticle 
with gamma-globulin coating (GG). The results indicated that there was a different pro-
tein corona associated to each of the various coatings, identifying the proteins by LC-MS/
MS. For instance, a greater number of lipoproteins and a low quantity of complement fac-
tors and immunoglobulins were found in HSA-coated nanoparticles, while the opposite 
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occurred in GG-coated nanoparticles, with higher levels of complement factors and opso-
nins, especially immunoglobulins, and low levels of lipoproteins. The presence of opsonins 
made the uptake more difficult, and when comparing with nanoparticles without protein 
corona, the differences in uptake were very significant, as nanoparticles without it entered 
the cells more easily.
Another work that explored the composition of the protein corona was provided by 
Mahmoudi et al. [90], who verified the alteration of the proteins that formed the corona 
after submitting it to plasmonic heat induction. In this experiment, gold nanorods were 
used and immersed in fetal bovine serum (FBS) at different concentrations – 10% to mimic 
in vitro milieu and 100% that mimic in vivo milieu. The protein corona was then evalu-
ated before and after exposure to plasmonic heat induction in both concentrations, and by 
LC-MS/MS, it was found that, at room temperature, at 10% FBS the most abundant proteins 
were apolipoprotein A-I precursor and the hemoglobin fetal subunit beta, while the least 
abundant was the apolipoprotein C-III precursor. At room temperature at 100% FBS, the 
protein corona was rich in the apolipoprotein A-II precursor and also in hemoglobin fetal 
subunit beta, while the most scarce was the apolipoprotein C-III precursor as well. After 
exposure to plasmonic heat induction, at 10% FBS the most abundant proteins became the 
α-2-HS-glycoprotein precursor and the apolipoprotein A-II precursor, while hemoglobin 
fetal subunit beta maintaining its numerousness and hemoglobin became the least frequent 
protein. At 100% FBS after plasmonic heat induction, α-2-HS-glycoprotein precursor also 
became the most frequent one, followed by hemoglobin fetal subunit beta as well, having 
a very significant decrease in the quantity of apolipoprotein A-II precursor but still hav-
ing the apolipoprotein C-III precursor as the least prevalent of all the proteins evaluated. 
Accordingly with these results [90], it is then possible to conclude that the protein corona’s 
composition is dependent on the medium where the nanoparticle is inserted, which, in this 
case, also translates to a difference between in vitro and in vivo applications of the nanopar-
ticle, being demonstrated as well its dependency on a physical factor (temperature), which 
must be taken into account when dealing with hyperthermic nanoparticles as a therapeutic 
method against tumors.
6. Conclusions
The study of the protein corona is still in a very embryonic stage, with many problems and 
questions yet to be answered, such as the composition when formed in most nanoparticles, 
exact description of the uptake and clearance mechanisms, and extensive reports on the con-
sequences of its formation. Some steps have been taken with the purpose of answering these 
questions, especially in resorting to bioinformatic approaches, allowing an easier and more 
efficient analysis and sharing of the data obtained. Nevertheless, these are without a doubt 
interesting research topics, leading the way to improve what is already a very auspicious field 
in nanomedicine.
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